Otsuka Holdings Co., Ltd.

Tokyo Stock Exchange:4578.T

Sector

🛒 Consumer Staples

Industries

🥤 Soft Drinks & Sodas

💄 Cosmetics

🥤 Non-Alcoholic Beverages

🧴 Personal Care

💊 Pharmaceuticals

Location

Japan

Market Cap

USD 25.86 B

Share Price

USD 48.96

Avg Daily Volume

1,353,972

Change (1 day)

-0.40%

Change (1 year)

17.94%

Change (YTD)

-10.65%

Otsuka Holdings Co., Ltd. Enterprise Value to EBITDA (EV/EBITDA) on June 27, 2025: 8.56

Otsuka Holdings Co., Ltd. Enterprise Value to EBITDA (EV/EBITDA) is 8.56 on June 27, 2025, a -33.88% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.

Otsuka Holdings Co., Ltd. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 19.95 on June 27, 2025, which is 133.10% above the current Enterprise Value to EBITDA (EV/EBITDA).
Otsuka Holdings Co., Ltd. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 7.38 on June 27, 2025, which is -13.75% below the current Enterprise Value to EBITDA (EV/EBITDA).
Otsuka Holdings Co., Ltd. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 14.15.

Daily

From:

To:

Zoom:

Key data

Date	Enterprise Value to EBITDA (EV/EBITDA)	Free Cash Flow Yield	Dividend Yield	Market Capitalization

Tokyo Stock Exchange: 4578.T

Otsuka Holdings Co., Ltd.

CEO	Mr. Makoto Inoue
IPO Date	Dec. 15, 2010
Location	Japan
Headquarters	2-9 Kanda-Tsukasamachi
Employees	35,338
Sector	🛒 Consumer Staples
Industries Soft Drinks & Sodas 💄 Cosmetics 🥤 Non-Alcoholic Beverages 🧴 Personal Care 💊 Pharmaceuticals

Description

Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a conditioning food product; BODYMAINTÉ Drink, a drinkable-liquid; POCARI SWEAT, a drink; Calorie Mate, a nutritional food; OS-1, an oral rehydration solution; HINEX-R, a concentrated liquid diet; and Oronine H Ointment, a household antiseptic medicine. In addition, the company offers soft drinks, food products, and wines; chemicals; clinical testing and medical equipment; cosmetics; warehousing and transport services; analysis and measurement equipment; pharmaceutical intermediates; vehicle headlight testers; synthetic resin molded products; paper products; artificial turf; ceramic boards, ceramic walls, reliefs, terracotta, OT ceramics, and ceramic portraits and sign boards; functional films; stable isotopes; software and services to enhance management of mental healthcare systems; potassium titanate; polyolefin foams; spring and mineral water; industrial chemicals; hydrazine; insecticide and toiletry products; and adhesive tapes. Further, it operates a hotel. Otsuka Holdings Co., Ltd. was founded in 1921 and is based in Tokyo, Japan.